Skip to main content

Table 2 Prevalence of HMOX1 genotypes and haplotypes in CAD patients and controls.

From: Genetic variants of the promoter of the heme oxygenase-1 gene and their influence on cardiovascular disease (The Ludwigshafen Risk and Cardiovascular Health Study)

HMOX1 genotype Controls CAD P 1
  N % N %  
A>T rs2071746      
AA 246 35.5 893 35.4  
AT 341 49.2 1181 46.8  
TT 106 15.3 452 17.9 0.245
A allele 833 60.1 2967 58.7  
T allele 553 39.9 2085 41.3 0.358
VNTR S <25, L ≥ 25 repeats      
SS 66 9.5 286 11.3  
SL 302 43.6 1070 42.4  
LL 325 46.9 1170 46.3 0.399
S allele 434 31.3 1642 32.5  
L allele 952 68.7 3410 67.5 0.402
VNTR S <27, L ≥ 27 repeats      
SS 93 13.4 370 14.6  
SL 328 47.3 1157 45.8  
LL 272 39.2 999 39.5 0.651
S allele 514 37.1 1897 37.5  
L allele 872 62.9 3155 62.5 0.752
Haplotype 22-T      
0 455 65.7 1631 64.6  
1 209 30.2 774 30.6  
2 29 4.2 121 4.8 0.752
other haplotypes 1119 80.7 4036 79.9  
22 – T 267 19.3 1016 20.1 0.484
Haplotype 29 – A      
0 185 26.7 718 28.4  
1 356 51.4 1243 49.2  
2 152 21.9 565 22.4 0.566
other haplotypes 726 52.4 2679 53.0  
29 – A 660 47.6 2373 47.0 0.669
  1. 1 Chi-squaredtest